Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) – Stock analysts at Dougherty & Co raised their FY2019 earnings per share (EPS) estimates for Allscripts Healthcare Solutions in a research note issued on Tuesday, May 7th. Dougherty & Co analyst G. Mannheimer now anticipates that the software maker will earn $0.49 per share for the year, up from their previous forecast of $0.48.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Thursday, May 2nd. The software maker reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.02. Allscripts Healthcare Solutions had a net margin of 20.60% and a return on equity of 6.92%. The company had revenue of $432.00 million for the quarter, compared to the consensus estimate of $436.47 million. During the same period in the prior year, the company posted $0.16 EPS. The company’s revenue was down .4% compared to the same quarter last year.
Other research analysts also recently issued reports about the stock. BidaskClub downgraded shares of Allscripts Healthcare Solutions from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 2nd. Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Monday, January 14th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. Allscripts Healthcare Solutions has a consensus rating of “Hold” and a consensus price target of $13.29.
Allscripts Healthcare Solutions stock opened at $10.28 on Friday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.08 and a current ratio of 1.04. Allscripts Healthcare Solutions has a 1 year low of $8.54 and a 1 year high of $14.97. The stock has a market cap of $1.71 billion, a price-to-earnings ratio of 18.69, a price-to-earnings-growth ratio of 1.51 and a beta of 1.29.
A number of institutional investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC raised its position in shares of Allscripts Healthcare Solutions by 492.2% in the 3rd quarter. AQR Capital Management LLC now owns 118,985 shares of the software maker’s stock valued at $1,696,000 after acquiring an additional 98,892 shares during the period. Teachers Advisors LLC raised its position in shares of Allscripts Healthcare Solutions by 0.6% in the 3rd quarter. Teachers Advisors LLC now owns 921,374 shares of the software maker’s stock valued at $13,130,000 after acquiring an additional 5,830 shares during the period. Vanguard Group Inc. raised its position in shares of Allscripts Healthcare Solutions by 1.0% in the 3rd quarter. Vanguard Group Inc. now owns 15,851,184 shares of the software maker’s stock valued at $225,880,000 after acquiring an additional 153,769 shares during the period. Marshall Wace LLP acquired a new stake in shares of Allscripts Healthcare Solutions in the 3rd quarter valued at approximately $1,406,000. Finally, Meeder Asset Management Inc. raised its position in shares of Allscripts Healthcare Solutions by 539.1% in the 4th quarter. Meeder Asset Management Inc. now owns 3,368 shares of the software maker’s stock valued at $32,000 after acquiring an additional 2,841 shares during the period.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.
Featured Story: Bollinger Bands
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.